title: [Vasobral in the treatment of brain lesions: views of physicians and patients].
abstract: A study was based on the survey of 419 neurologists and 1189 their patients with different forms of cerebrovascular diseases using a specially developed questionnaire. In most cases, vasobral was used as a monotherapy or in a complex treatment. Twenty-two percent of physicians reported that vasobral was the most effective compared to other drugs. The good tolerability of treatment (18%) and the broad spectrum of indications and clinical effects (17%) were reported as well. The large percentage (75%) of patients indicated the positive effect of vasobral on memory, reasoning, vertigo etc The maximal effect was identified in the treatment of mild cognitive impairment caused by chronic brain ischemia and vertebrobasilar insufficiency. Vasobral is recommended for a use in a complex therapy in patients with more severe brain lesions and cognitive deficit.
authors.forename: P R
authors.initials: PR
authors.lastname: Kamchatnov
mesh_terms: D002110:Caffeine / Q000627:therapeutic use*; D002561:Cerebrovascular Disorders / Q000150:complications / Q000188:drug therapy*; D003071:Cognition / Q000187:drug effects; D003072:Cognition Disorders / Q000188:drug therapy / Q000209:etiology; D004088:Dihydroergotoxine / Q000627:therapeutic use*; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008568:Memory / Q000187:drug effects; D010361:Patients; D010820:Physicians; D011795:Surveys and Questionnaires; D014717:Vertigo / Q000188:drug therapy / Q000209:etiology
chemical_list: D004338:Drug Combinations; D004088:Dihydroergotoxine; D002110:Caffeine; C055581:Vasobral